[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.238.168. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
May 1977

Betamethasone Valerate Ointment Compared With Fluocinonide FAPGUse in the Treatment of Psoriasis and Eczema

Author Affiliations

From St Bartholomew's Hospital (Dr Munro); University College Hospital (Drs Robinson and France); St Mary's Hospital (Drs du Vivier and Clayton), London; and the Clinical Research Unit, Glaxo Laboratories Ltd, Greenford, England (Dr Sparkes). Dr France is now with the Crawley Hospital, Crawley, Sussex, England.

Arch Dermatol. 1977;113(5):599-601. doi:10.1001/archderm.1977.01640050059006
Abstract

• Betamethasone 0.1% as valerate in an ointment base and fluocinonide 0.05% in a fatty alcohol propylene glycol (FAPG) base have been compared in a double-blind trial of 76 patients with either eczema or psoriasis. The results show betamethasone valerate ointment to be significantly (P < .05) superior to fluocinonide FAPG in the treatment of both these skin conditions. In the light of publications from other studies on betamethasone valerate cream this trial indicates that the ointment base considerably increases the efficacy of betamethasone valerate.

(Arch Dermatol 113:599-601, 1977)

×